# A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

> **NCT04035538** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 42 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CKD-320, D012

## Key facts

- **NCT ID:** NCT04035538
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08
- **Primary completion:** 2019-11
- **Final completion:** 2019-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2019-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04035538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04035538, "A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04035538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*